October marked the third month in a row that recreational sales hovered around the $85 million mark, while medical marijuana sales dipped to $25.3 million.
Throughout 2023, medical sales have remained about one-third of the amount of adult-use recreational, which has led to the lowest medical use sales figure ever since competition with the recreational program began in January 2021.
The last time medical sales were above $30 million was in May 2023, and the medical market has not surpassed $40 million since June 2022. Medical sales have declined consistently since a peak of $73.4 million in April 2021.
The program continues to bleed participants as two-year medical cards expire and qualified users opt out of the $150 biannual certification fee and other costs associated with maintaining medical qualification.
Recreational sales have fluctuated between $80 million and $93.5 million since July 2022, with the exception of a record $100.2 million in March 2023.
Since the first time the recreational market passed the $80 million threshold in March 2022, it has only failed to reach that mark twice — once in May 2022, when it registered $79.3 million, and in June 2022, when sales were $77.2 million.
Through October 2023, medical cannabis sales…
